Skip to main content
TipRanks
Go Ultimate75% OFF

AstraZeneca (AZN) Stock Statistics & Valuation Metrics

1,062 Followers

Total Valuation

AstraZeneca has a market cap or net worth of GBX 211.64B. The enterprise value is GBX 211.22B.

Market Cap
GBX 211.64B
Enterprise Value
GBX 211.22B

Share Statistics

AstraZeneca has 1,551,065,200 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
1,551,065,200
Owned by Insiders
0.04%
Owned by Institutions
50.65%

Financial Efficiency

AstraZeneca’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 13.04%.

Return on Equity (ROE)
0.21
Return on Assets (ROA)
0.09
Return on Invested Capital (ROIC)
13.04%
Return on Capital Employed (ROCE)
0.16
Revenue Per Employee
611.23K
Profits Per Employee
106.40K
Employee Count
96,100
Asset Turnover
0.51
Inventory Turnover
1.62

Valuation Ratios

The current PE Ratio of AstraZeneca is 25.19. AstraZeneca’s PEG ratio is 1.52.

PE Ratio
25.19
PS Ratio
4.46
PB Ratio
5.41
Price to FCF
30.57
Price to Operating Cash Flow
20.82
PEG Ratio
1.52

Income Statement

In the last 12 months, AstraZeneca had revenue of 58.74B and earned 10.22B in profits. Earnings per share was 6.60.

Revenue
58.74B
Gross Profit
48.11B
Operating Income
13.74B
Pretax Income
12.40B
Net Income
10.22B
EBITDA
19.83B
Earnings Per Share (EPS)
6.60

Cash Flow

In the last 12 months, operating cash flow was 13.36B and capital expenditures -4.26B, giving a free cash flow of 9.10B billion.

Operating Cash Flow
13.36B
Free Cash Flow
9.10B
Free Cash Flow per Share
5.87

Dividends & Yields

AstraZeneca pays an annual dividend of GBX 159.50, resulting in a dividend yield of 1.75%

Dividend Per Share
GBX 159.50
Dividend Yield
1.75%
Payout Ratio
34.12%
Free Cash Flow Yield
3.27%
Earnings Yield
3.97%

Stock Price Statistics

Beta
1.14
52-Week Price Change
0.59%
50-Day Moving Average
12709.92
200-Day Moving Average
13377.84
Relative Strength Index (RSI)
56.21
Average Volume (3m)
2.76M

Important Dates

AstraZeneca upcoming earnings date is Feb 11, 2027, TBA (Not Confirmed).

Last Earnings Date
Oct 30, 2026
Next Earnings Date
Feb 11, 2027
Ex-Dividend Date
Feb 19, 2026

Financial Position

AstraZeneca as a current ratio of 0.94, with Debt / Equity ratio of 60.87%

Current Ratio
0.94
Quick Ratio
0.72
Debt to Market Cap
0.10
Net Debt to EBITDA
1.21
Interest Coverage Ratio
8.11

Taxes

In the past 12 months, AstraZeneca has paid 2.17B in taxes.

Income Tax
2.17B
Effective Tax Rate
0.17

Enterprise Valuation

AstraZeneca EV to EBITDA ratio is 14.25, with an EV/FCF ratio of 33.45.

EV to Sales
4.88
EV to EBITDA
14.25
EV to Free Cash Flow
33.45
EV to Operating Cash Flow
22.77

Balance Sheet

AstraZeneca has GBX 8.11B in cash and marketable securities with GBX 33.97B in debt, giving a net cash position of -GBX 25.86B billion.

Cash & Marketable Securities
GBX 8.11B
Total Debt
GBX 33.97B
Net Cash
-GBX 25.86B
Net Cash Per Share
-GBX 16.67
Tangible Book Value Per Share
-GBX 4.80

Margins

Gross margin is 77.59%, with operating margin of 23.60%, and net profit margin of 17.69%.

Gross Margin
77.59%
Operating Margin
23.60%
Pretax Margin
21.33%
Net Profit Margin
17.69%
EBITDA Margin
34.21%
EBIT Margin
23.91%

Analyst Forecast

The average price target for AstraZeneca is GBX 16.22K, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
GBX 16.22K
Price Target Upside
18.83% Upside
Analyst Consensus
Strong Buy
Analyst Count
17
Revenue Growth Forecast
4.55%
EPS Growth Forecast
14.19%

Scores

Smart Score
10
AI Score
73